$ cat ./records/india-cuts-the-gates-foundation-from-its-vaccine-policy-body-over-2017.txt
India Cuts the Gates Foundation From Its Vaccine-Policy Body Over Conflict-of-Interest Fears
[RECORD.TXT] · cat --full
In February 2017, the Indian government severed financial ties between the Gates Foundation and its key vaccine-policy body, the National Technical Advisory Group on Immunization (NTAGI) — which the foundation had funded through a technical-support unit — over concerns about potential conflicts of interest, given the foundation's links to vaccine alliances and pharmaceutical partners. Officials told Reuters they had found no actual improper influence but acted on the 'perception' that an outside funder could sway policy, moving the program fully in-house. The episode highlighted unease about the foundation's deep, sometimes opaque influence over national health policy.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Politico Dubs Bill Gates 'the World's Most Powerful Doctor' Over His Sway at the WHO
Next →
Gates Pledges $1.7 Billion to K-12 Education After Earlier Reform Bets Disappoint
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.